Using the ELF test, FIB-4 and NAFLD fibrosis score to screen the population for liver disease
Maria Kjærgaard(Central Denmark Region), Aleksander Krag(University of Southern Denmark), Peter Andersen(Odense University Hospital), Katrine Prier Lindvig(University of Southern Denmark), Jørgen Ellegaard Andersen(University of Southern Denmark), Mads Israelsen(University of Southern Denmark), Isabel Graupera(Hospital Clínic de Barcelona), Stine Johansen(University of Southern Denmark), Shan Shan(Jiangxi Normal University), Johanne Kragh Hansen(Odense University Hospital), Nikolaj Torp(University of Southern Denmark), Maja Thiele(Odense University Hospital), Pere Ginès(Hospital Clínic de Barcelona), Morten Beck Trelle(University of Southern Denmark), Nanna Kastrup(Aalborg University), Sönke Detlefsen(Odense University Hospital), Jane Møller Jensen(Odense University Hospital), Camilla Dalby Hansen(University of Southern Denmark), Steen Antonsen(Odense University Hospital), Katrine Holtz Thorhauge(University of Southern Denmark)
Cited by 213
Related Papers
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
|Journal of Hepatology|2018|2.8k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Compensated cirrhosis: Natural history and prognostic factors
|Hepatology|1987|1.1k
EFSUMB Guidelines and Recommendations on the Clinical Use of Liver Ultrasound Elastography, Update 2017 (Long Version)
|Ultraschall in der Medizin - European Journal of Ultrasound|2017|998